Baxter International (BAX) Other Non-Current Liabilities (2009 - 2026)
Baxter International (BAX) posted quarterly Other Non-Current Liabilities of $1.2 billion for Q2 2026, up 9.21% year-over-year from $1.1 billion in Q2 2025, and down 7.28% quarter-over-quarter from $1.3 billion in Q1 2026.
Baxter International (BAX) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Other Non-Current Liabilities for 18 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Liabilities rose 9.21% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.2 billion (up 9.21% YoY), while the FY2025 annual figure was $1.3 billion, up 19.61% from the prior year.
- Other Non-Current Liabilities fell to $1.2 billion in Q2 2026 per BAX's latest filing, from $1.3 billion in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.4 billion in Q1 2022 and bottomed at $1.1 billion in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 48.78% — and 2025, when it tumbled 32.08%.
- Baxter International's Other Non-Current Liabilities stood at $1.8 billion in 2022, then decreased by 24.24% to $1.4 billion in 2023, then fell by 23.14% to $1.1 billion in 2024, then climbed by 19.61% to $1.3 billion in 2025, then decreased by 6.92% to $1.2 billion in 2026.
- Business Quant data shows BAX's Other Non-Current Liabilities at $1.2 billion in Q2 2026, $1.3 billion in Q1 2026, and $1.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Bn |
| Mar 31, 2026 | 1.29 Bn |
| Dec 31, 2025 | 1.29 Bn |
| Sep 30, 2025 | 1.12 Bn |
| Jun 30, 2025 | 1.10 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.08 Bn |
| Sep 30, 2024 | 1.26 Bn |
| Jun 30, 2024 | 1.60 Bn |
| Mar 31, 2024 | 1.65 Bn |
| Dec 31, 2023 | 1.40 Bn |
| Sep 30, 2023 | 1.78 Bn |
| Jun 30, 2023 | 1.62 Bn |
| Mar 31, 2023 | 1.85 Bn |
| Dec 31, 2022 | 1.85 Bn |
| Sep 30, 2022 | 2.07 Bn |
| Jun 30, 2022 | 2.26 Bn |
| Mar 31, 2022 | 2.43 Bn |
| Dec 31, 2021 | 2.49 Bn |
| Sep 30, 2021 | 1.62 Bn |